产品详情
| 中文名称:3,3,20,20-双(亚乙二氧基)- 5α,17α-二羟基-11β-[4-(N,N-二甲基氨基)-苯基]-19-去甲孕甾-9(11)-烯 | 英文名称:3,3,3,20,20-Bis(ethylene-dioxy) -5alpha,17alpha-dihydroxy-11beta-[4-(N, N-dimethylamino)-phenyl]-19-norpregna-9(11)-ene; |
| CAS:126690-41-3 | 有效期: 一年 |
2024-03-28
3,3,20,20-双(亚乙二氧基)- 5α,17α-二羟基-11β-[4-(N,N-二甲基氨基)-苯基]-19-去甲孕甾-9(11)-烯
3,3,3,20,20-Bis(ethylene-dioxy) -5alpha,17alpha-dihydroxy-11beta-[4-(N, N-dimethylamino)-phenyl]-19-norpregna-9(11)-ene;
RMB
一年
醋酸优力司特中间体、醋酸乌利司他中间体126690-41-3
中文名称：3,3,20,20-双(亚乙二氧基)- 5α,17α-二羟基-11β-[4-(N,N-二甲基氨基)-苯基]-19-去甲孕甾-9(11)-烯
英文名称：3,3,3,20,20-Bis(ethylene-dioxy) -5alpha,17alpha-dihydroxy-11beta-[4-(N, N-dimethylamino)-phenyl]-19-norpregna-9(11)-ene;
CAS 号：126690-41-3
含量标准：98% HPLC
关键字： 醋酸优力司特；醋酸乌利司他；126690-41-3；CAS 126690-41-3
公司简介
We are offering three key services for new drug application,
a. Mature(repeatable) pilot process with independent intellectual property rights;
b. High purity sample designed for pharm companies;
c. Impurity study.
Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.
| 成立日期 |
2007-12-04
（17年）
|
注册资本 |
1500万元人民币
|
| 员工人数 |
100-500人 |
年营业额 |
￥ 5000万-1亿 |
| 主营行业 |
医药中间体,医药中间体,原料药,原料药 |
经营模式 |
工厂,工厂 |